|

KQ-2002 CAR-T cells （CD19/CD22 CAR T-Cells） Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Rong Tao1

Indications

  • B-cell Lymphoma Refractory1
  • B-cell Lymphoma Recurrent1
  • Acute Lymphoblastic Leukemia With Failed Remission1
  • Acute Lymphoblastic Leukemia, in Relapse1
  • Cancer1

Other1 trial

CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.